Cheng-Chiu is the Director of Portfolio and Pipeline Management at Ansun Biopharma. He received his postdoctoral training in neural circuit formation and peripheral neuropathy from HHMI-Janelia Research Campus and Washington University in St. Louis, after getting his Ph.D. from Baylor College of Medicine. Before joining Ansun, Cheng-Chiu worked at Merck and TLC Biopharmaceuticals. Cheng-Chiu is passionate about drug discovery, corporate development, science communication, as well as amateur volleyball games.